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Abstract: Chronic wound such as diabetic foot ulcer (dfu) is commonly resistant to conventional methods 
andassociated with foot complications. Delay in the healing of diabetic foot ulcers could lead to devastating 
complications such as infection, gangrene and lower limb amputations. Thus, effective management of dfu is 
crucial to expedite healing. Management of dfu requires efficient wound debridement to remove slough, necrotic 
tissue, prepare the wound for healing and closure. Maggot debridement therapy or MDT has been widely used 
in the debridement of chronic wounds and shown promising findings. However, MDT studies in the treatment of 
dfu remained less in number. Consequently, the comparison study between MDT and conventional method in 
dfu remained limited and inconclusive. The aim of the study was to evaluate the efficacy of MDT using local 
species Luciliacuprinaas compared to the non-surgical conventional method in the treatment of dfu based on 
slough percentage and size of ulcer on day 3, 6,9. The study also assessed the relationship between patients’ 
demography, clinical characteristics, and slough percentage. The study was conducted in UMMC, tertiary 
healthcare setting on 110 adult diabetics (55 in each group) with sloughy ulcer below 40cm
2
, less than 2cm 
deep, ankle-brachial index ABI of 0.8 or higher. Slough and size were measured using NDKare
TM
 app.The result 
showed a significant difference in slough percentage on day 3,6 and 9 between both groups (p<0.001). 
Reduction of slough was faster in MDT group on day 3, complete debridement on day 6 whereas there was still 
67.31% of slough in the conventional group on day 9. However, size reduction was not significantly different 
between both groups. The site of ulcer was shown to have a significant relationship with slough percentage in 
the study. Due to rapid in time to debridement with MDT, it is highly recommended that MDT is integrated into 
the treatment of dfu to prevent foot complications especially lower limb amputations. 
Background: The prevalenceof diabetesmellitusisincreasingrapidlyworldwide.Diabetic foot complications are 
devastatingwhichinclude infection, gangrene, and lowerlimb amputations. Managingdfu has been a 
costlyaffairespecially in developing countriessuch as Malaysia. Complication of dfuincreasedhealthcareburden 
and reducedquality of life dordiabetics.MDT hadshowntremendousoutcomes in the debridement of 
chronicwounds for decadessince World War 1. Mostly, MDT has beenusedworldwideas the last option in 
limbsalvaging for patients withdfu.Studies on the effectiveness of MDT in the treatment of dfu are stilllacking 
and remaininconclusive. Benefits of MDT has been demonstrated in previousstudies in removingslough, 
necrotic tissue and acceleratingchronicwoundhealing.Successfuloutcomeswith MDT couldpreventfoot 
complications, reduceincidences of infection, gangrene and lowerlimb amputations. Despiteadvancements in 
wound care technology, the management of dfu has been resistant to conventionalmethods and challenging for 
clinicians.Hence, MDT could serve as an effective debridement method to manage DFU.  
Materials and Methods: In this prospective controlled study, 110 adult diabetic patients with sloughy DFU of 
Grade II, III and ABI>0.8 were included. The 110 patients were allocated into 2 groups of 55 patients each 
(MDT Group and Conventional Group). The patients were followed for 9 days. The efficacy of MDT was 
compared to a non-surgical conventional method based on slough percentage and size of ulcer at baseline, day 
3, day 6, day 9 using the validated wound monitoring system NDKare
TM
. The relationship between patient 
socio-demography, diabetes and ulcer clinical characteristics were evaluated.  
Results: Time to debridement was shorter in MDT Group as compared to Conventional Group. Rapid reduction 
in slough percentage within 3 days was observed in MDT Group (200 maggots) as compared to the 
conventional method. Complete debridement was achieved in 6, 9 days in ulcers treated with MDT (400 
maggots) whereas there was still a mean 67.31% slough in the conventional group in the Conventional Group. 
The differences in the mean slough percentage between the two groups were statistically significant (p<0.001). 
However, the mean size of ulcer was not significantly different between MDT and Conventional group due to 
non-homogeneity of size at baseline. The site of ulcer was significantly associated with a slough percentage in 
the study population.  
Conclusion: MDT was significantly more effective than conventional method in the treatment of DFU 
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I. Introduction 
 Incidences of DFU had been on an upward trend due to the increase of diabetes prevalence worldwide. 
As TheInternational Diabetes Federation (2017) reported, there are more than 400 million adult diabetics 
globally and the numbers are on the rise. It was estimated 25% of diabetics with poor control of glucose will 
develop a foot ulcer in their lifetime and DFU has been the major indication for lower limb amputation.
1
 
Complications of DFU has become a healthcare burden for developing countries, negatively affected the 
patients’ economic standpoint and quality of life.
2
Majority of the complications of DFU includes infection, 
gangrene and lower limb amputation that can be prevented with effective chronic wound management as stated 
in T.I.M.E framework (T=tissue management/debridement, I=infection/inflammation, M=moisture balance, 
E=advancing edges).
3,4,5
 Tissue management via effective debridement is crucial in wound bed preparation to 
accelerate healing. 
6,7 
The purpose of debridement is to remove slough, necrotic, non-viable tissue, promote 
granulation, and eventually epithelialization. In addition, debridement also plays a pivotal role in controlling 
infections. Therefore, the benefits of debridement are irrefutable in the management of chronic wounds.
8 
MDT 
had been effective in debriding chronic and infected wounds, DFUs, venous ulcers, and pressure ulcers since its 
inception in the 19
th
 century. Initial investigations had revealed that the healing of chronic wounds was 
expedited due to the debridement effect of sterile maggots in removing 25mg of slough and necrotic tissue 
within 24 hours. 
9,10 
In view of the chronicity of DFU, the usage of the century-old MDT had gained momentum 
and been advocated for debridement purposes in healthcare settings.
11
Due to this effect, MDT had been 
explored in chronic wound debridement when the conventional method failed to achieve the targeted outcomes. 
Nevertheless, MDT is mostly utilized as a last option for limb salvaging in actual clinical settings as 
demonstrated in a majority of clinical observations with MDT.
12,13,14 
MDT had been prescribed as bio-surgery, 
larval therapy, maggot debridement therapy or maggot therapy referring to the application of medical-grade 
sterile larvae on chronic wounds.
15,16,17,18
Selection of an effective debridement tool could optimize wound bed 
preparation to prevent delay in healing.
19 
MDT using sterile maggots of Luciliasericatahad shown promising 
outcomes for decades in removing slough and necrotic tissue as revealed in previous studies. 
20,21
However, 
comparison studies between MDT and conventional method (surgical and non-surgical) in the treatment of non-
healing DFUs remain sparse. 
23
Despite advancements in technology, MDT had stood the test of time and 
emerged as a promising tool for debridement in chronic wounds.
24
However, not all species of flies were safe 
and effective for wound debridement. The sterile larvae of greenbottle blowflies, Luciliasericata and 
Luciliacuprina (Diptera: Calliphoridae) have been used for the debridement of chronic wounds. 
25,26
However, 
the majority of the MDT studies were conducted with Luciliasericata which is abundantly present in Europe. 
Less studies had been published with Luciliacuprina which is mainly found in Asia and Africa. 
27,28
When 
conventional debridement methods failed to yield positive outcomes, MDT had been an alternative debridement 
modality for limb salvaging used by clinicians  mainly in Europe and the USA.
29,30
The striking effect of MDT 
was based on its three major modes of actions which include debridement, disinfection, and stimulation of 
wound healing.
31,32,33
In Malaysia, the investigation into the efficacy of MDT using Luciliacuprina did not 
produce significant outcomes and inconclusive.Hence, the main objective of the study is to evaluate the 
effectiveness of MDT in the treatment of DFU as compared to conventional method based on reduction in 
slough percentage on day 3, 6, 9 and size of ulcer in 9 days.  
 
Material And Methods:This prospective controlled study was conductedin University Malaya Medical Centre, 
Malaysia from September 2018 to April 2019 on a total 110 adult diabetic patients aged ≥ 18 years with sloughy 
Grade II, Grade III DFU (both male and females) with ankle brachial index ABI>0.8. 
Study Design: Prospective controlled observational study 
Study Location: Tertiary care teaching hospital, UMMC 
Study Duration:September 2017 to November 2019. 
Sample size: 110 patients. 
Sample size calculation: The sample size was calculated based on a previous MDT study by Opletalová et al. 
(2012) with an assumption of a 20% mean reduction in slough or necrotic tissue using MDT with an error 
estimate of 5% and 80% probability of detecting the effect of application with MDT. The calculation of sample 
size in the present study revealed a minimum of 55 participants in each group (MDT and conventional group).  
Subjects & selection method: The participants for the study were selected when based on their consent for 
MDT. Patients consented for MDT are allocated into the MDT Group and others in the conventional group at 
the Orthopaedic Ward in UMMC.  Patient socio-demography data such as age, gender and diabetes history, 
HbA1c, type of diabetes are documented during the admission of patients to the ward. 
 
Inclusion criteria: 
1. Adult diabetic patients with sloughy, Wagner DFU Grade II,III 
2. Both male and female 
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3. No profuse bleeding 
4. ABI>0.8 
5. Single wound in each limb 
6. No sepsis and require urgent debridement 
 
Exclusion criteria: 
1. Non-diabetic based foot ulcers 
2. Less than 18 years of age 
3. ABI<0.8 
4. Multiple ulcers in the same limb. 
5. Sepsis and require urgent debridement 
 
Procedure methodology 
The selection of patients for the study was selected by doctors in the Orthopaedic Ward based on the 
inclusion and exclusion criteria. After getting informed consent from the patients, they were admitted to the 
ward. Baseline characteristics of the patients (age, gender), diabetes history, HbA1c, type of diabetes and ulcer 
characteristics (grade, size, site, and duration of ulcer) was documented. Size of ulcer and slough percentage 
was measured using the wound monitoring app NDKare
TM
 at baseline, day 3, day 6 and day 9. 
 
Statistical analysis 
Data were analyzed using SPSS version 23 (SPSS Inc., Chicago, IL). Normality in the distribution of 
data was tested with skewness and kurtosis test. If the numerical values of skewness and kurtosis were between -
1.96 and 1.96 and were established as normal distribution of data Repeated measures Rm-ANCOVA with size 
as covariate was applied to ascertain the difference between the two groups in relation to slough percentage. 
Independent samplet-test was used to determine the significance of differences between the two groups in 
relation to mean size of ulcer. In addition, Spearman, Pearson and Mann-Whitney statistical test was used to 
determine the relationship between age, gender, diabetes history, HbA1c, type of diabetes and ulcer 




After 9 days of follow up, rapid debridement was observed MDT from baseline (80%)  to day 3 (13%) 
with 1 cycle of MDT and  complete debridement in 6 days whereas there was still 67.3% slough in the ulcers 
treated with conventional method (saline moistened gauze, paraffin gauze). The differences between the mean 
percentage of slough was statistically significant (p<0.001). However, the reduction of size was not significantly 
different between both groups from baseline to day 9. The site ulcer had shown significant relationship with 
slough percentage in the study population. 
 
Figure 1: Profile plot showing the efficacy of MDT as compared to conventional method in DFU  
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Figure 1: Significant slough reduction in the shortest time was achieved in the ulcers treated with MDT as 
compared to ulcers treated with the conventional method from baseline to day 3, 6, 9. The findings of Rm-
ANCOVA with Bonferroni adjustments showed the average slough percentage at baseline was homogenous 
between both groups and not significantly different (p=0.522). However, the differences in the mean percentage 
of slough were demonstrated to be statistically significant (p<0.001) across different time points; day 3, day 6, 
and day 9 between the MDT and Conventional groups. At day 3, the percentage of slough reduced to 13.71% in 
MDT compared to 80.25% of slough in the conventional group. The data analysis showed that there were almost 
no changes in the percentage of slough at baseline and day 3 in the conventional group. In comparison to the 
percentage of slough in the conventional group (75.62%), the ulcers in MDT group were successfully debrided 
on day 6 (zero slough). On day 9, ulcers in MDT still maintained with no slough whereas there was still 67.31% 
slough percentage in the conventional group.  Overall, the ulcers in MDT group achieved a significant reduction 
in slough percentage on day 3 and continued to achieve complete debridement on day 6 as compared to ulcers in 
the conventional group. Hence, ulcers treated with MDT achieved significant reduction in slough percentage 
and complete debridement faster than the conventional method. 
 
Table 3: Relationship between independent variables and  percentage of slough 
  (n=110) 
Research variables Statistical test p value 
 
    
Age Pearson's correlation, r =0.095 p=0.323 
   Gender Independent sample p=0.61 
 
Mann-Whitney U test 
 
   Type of diabetes Independent sample t test p=0.292 
   HbA1c Pearson's correlation, r = -0.119 p=0.215 




   
Grade of ulcer 
Independent samples p=0.326 
Mann-Whitney U test 
 
   Size of ulcer Pearson's correlation, r =-0.115 p=0.232 
   Site of ulcer Spearman's correlation, rs= 0.269* p=0.004 
   Duration of ulcer Spearman's correlation, rs = 0.095 p=0.321 
      
*Correlation is significant at the 0.05 level (2 tailed) 
 
 
   
 
  
The secondary objective of the present study was to evaluate the relationship between selected 
independent variables such age, gender, type of diabetes, HbA1c, duration of diabetes, grade of ulcer, duration 
of ulcer, site of ulcer with the dependent variable (percentage of slough) among the 110 participants in the 
study. The findings revealed no significant relationship between selected research variables such as age, gender, 
type of diabetes, HbA1c, duration of diabetes, grade of ulcer, size of ulcer, duration of ulcer, and slough 
percentage in the study population. The only variable which indicated a significant relationship with slough 
percentage was the site of ulcer. The site of ulcer showed a positive correlation with the percentage of slough 
(Spearman’s correlation, rs=0.269, p=0.004). 
 
III. Discussion 
The study population of 110 adult patients with DFU comprised of more males than females with an 
average age 61.5 years. Majority of study population had been diabetic for more than 10 years whereas diabetes 
history of 5 years. Type I and Type II diabetes were equally represented in the study population with poor 
control of glucose (8%). Most of the DFU fell under Grade 3 Wagner classification with a ulcer history of more 
than 6 months, the least was less than 6 weeks. DFUs in the study were predominantly represented at the plantar 
region followed by forefoot, dorsum and hindfoot (least). All the baseline characteristics such as age, gender, 
type of diabetes, HbA1c, duration of diabetes, grade of ulcer, site and duration of ulcer were homogenous 
between both groups except for size of ulcer. The average size of ulcer in MDT group was 2x bigger than 
conventional group at baseline. The statistical analysis showed normal distribution of data in the study 
population based on the numerical value of skewness and kurtosis. In view of the normal distribution of data, 
repeated-measure (Rm)ANCOVA was performed (size as covariate) to compare mean slough percentage 
between MDT and conventional group at baseline, day 3, day 6 and day 9. The findings indicated there were 
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significant differences between both groups in relation to slough percentage at day 3, day 6, and day 9 in the 
present study.  Slough reduction was significantly faster in 3 days with MDT as compared to conventional 
method. Complete debridement was achieved on day 6 and maintained zero slough till day 9 whereas there was 
still 67.31% of slough in the conventional group on day 9. Independent sample t-test was performed to compare 
average wound size between both groups from baseline to day 9.  Due to the non-homogeneity of wound size at 
baseline, therefore the wound size was not concluded to be significant at day 3, day 6 and day 9. However, the 





) from baseline to day 9. The findings also indicated the site of ulcer had a significant relationship with 
the slough percentage in the present study. Overall, the result showed MDT was significantly more effective 
than conventional method in the treatment of DFU based on slough reduction at day 3, day 6 and day 9. 
 Slough is a common phenomenon in DFU and prolonged existence of slough promotes infection, 
biofilm, and impede healing. Therefore, slough must be removed from the wound bed to promote granulation 
and wound closure. Reduction in slough could lead to faster healing and lesser foot complications among 
diabetics.
33
 The primary outcome of the present study showed that reduction of slough percentage was higher in 
the MDT group as compared to the conventional method. Time to debridement was proven to be shorter in 
MDT group as compared to conventional group at day 3, day 6 and day 9. Time to debridement is defined as 
time taken to remove slough/necrotic tissue from the wound bed. Rapid debridement was achieved in 3 days and 
complete debridement in 6 days. The ulcers in the conventional group did not even 50% slough reduction on day 
9, whereby there was still 67.31% average mean slough on day 9. The differences in slough percentage between 
MDT and conventional method was statistically significant (p<0.001). Based on the result, MDT is more 
effective than the conventional method in the treatment of DFU than conventional method from baseline to day 
3, day 6 and day 9. Since there is the difference in slough percentage was statistically significant, therefore 
Alternative hypothesis is accepted.  
To the researcher’s knowledge, the findings in the present study were the first to demonstrate 
significant shorter time to debridement with MDT on day 3 and complete debridement on day 6, 9 in DFU 
treated with MDT using Luciliacuprina. Undoubtedly, the findings of the present study corroborate with 
previous comparison studies between MDT and conventional method in DFU as mentioned in the literature 
review.
34,35
 However, the findings in the study by Sherman (2003) and Azad et al (2016) showed time taken to 
achieve complete debridement was one month as compared to 6 days in the present study. In one study by 
Opletalová et al. (2012)
36
 on non-diabetic based foot ulcer, significant slough reduction with MDT was observed 
on day 8 (54.5% ) as compared to control group (66.5%). In a similar finding
37
, complete debridement was 
achieved in 1.9 weeks in 10 patients treated with MDT. Averagely,the time taken to achieve rapid debridement 
was within 2 weeks and complete debridement within 4 weeks as reported in previous studies with MDT in 
previous studies.
37,38
 The finding in the present study is considered to be the shortest significant time to 
debridement observed with MDT using Luciliacuprina. Ultimately, the outcome of the present study 
demonstrated the superior efficacy of MDT in debriding DFUs as compared to the conventional method (non-
surgical). The significant reduction in slough percentage within 3-6 days with 1-2 cycle of maggot application 
(200 maggots each cycle) had revealed the excellent potential benefit of MDT in the debridement of DFU.  
 
IV. Conclusion 
Chronic wounds such as dfu will not be able to heal without effective debridement. Debridement 
enables devitalized tissue to be removed from the wound bed which is a barrier for granulation of tissue and 
further treatment of the wound for. Rapid and effective debridement of diabetic foot ulcer with MDT had been 
demonstrated as compared to conventional method in the present study. Most of the published articles supported 
the use of MDT for debridement but without conclusive outcomes with statistical significance. The significant 
findings in the present study had increased the evidence base for MDT with Luciliacuprina in the treatment of 
dfus in Malaysia. This may bring MDT a step closer to be integrated into debridement protocol of dfuin 
healthcare settings to improve healing outcomes. Since the site of ulcer was the only factor which had been 
shown in the study to affect the slough percentage, consideration of the offloading needs to be implemented for 
plantar regions to enhance faster healing. Based on the findings, MDT should be considered as the first line in 
the debridement protocol of indicated diabetic foot ulcers with sloughy, necrotic tissue and not as the last option 
in chronic wound management. Delay in debridement could imminently prolong wound healing which 
ultimately cause foot complication and in worst case, lower limb amputation. However, there were a few 
limitations.Due to the time and cost constraints, the present study was a short-term prospective controlled study 
for 9 days. A longer period of study could have been helpful to determine the continuous effect of MDT in the 
reduction of slough percentage till wound closure. Furthermore, recurrent of slough presentation in diabetic foot 
ulcers and the effect of maintenance debridement with MDT could have been investigated if the study was 
conducted for a minimum of 4 weeks. Another limitation was the size of the diabetic foot ulcer. The size of 
ulcer in the MDT group was double the size of ulcers in the conventional   group. Homogenous size of ulcer 
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between MDT and CVT group could have enhanced precision in the evaluation of size reduction in the present 
study. Furthermore, it was difficult to recruit participants with similar size of ulcer in the actual clinical setting 
in a short span of time. Therefore, future studies with MDT should consider a minimum of 4 week study 
duration to investigate the efficacy 
 
References 
[1]. Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018). IDF 
Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical 
Practice, 138.  
[2]. Raghav, A., Khan, Z. A., Labala, R. K., Ahmad, J., Noor, S., & Mishra, B. K. (2018, January 1). Financial burden of diabetic foot 
ulcers to world: a progressive topic to discuss always. Therapeutic Advances in Endocrinology and Metabolism, Vol. 9, pp. 29–31.  
[3]. Coffey, L., Mahon, C., & Gallagher, P. (2019). Perceptions and experiences of diabetic foot ulceration and foot care in people with 
diabetes: A qualitative meta-synthesis. International Wound Journal, 16(1).  
[4]. Pritchard, David I., Čeřovský, V., Nigam, Y., Pickles, S. F., Cazander, G., Nibbering, P. H., Jung, W. (2016). TIME managemen t 
by medicinal larvae. International Wound Journal, 13(4), 475–484.  
[5]. Bus, S. A., Armstrong, D. G., van Deursen, R. W., Lewis, J. E. A., Caravaggi, C. F., & Cavanagh, P. R. (2016). IWGDF guidance 
on footwear and offloading interventions to prevent and heal foot ulcers in patients with diabetes. Diabetes/Metabolism Research 
and Reviews, 32.  
[6]. Lavery, L. A., Davis, K. E., Berriman, S. J., Braun, L., Nichols, A., Kim, P. J., … Attinger, C. (2016). WHS guidelines update: 
Diabetic foot ulcer treatment guidelines. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] 
the European Tissue Repair Society, 24(1), 112–126.  
[7]. Panuncialman, J., & Falanga, V. (2009). The Science of Wound Bed Preparation. Surgical Clinics of North America, 89(3), 611–
626.  
[8]. Sherman, Ronald A. (2014). Mechanisms of maggot-induced wound healing: What do we know, and where do we go from here? 
Evidence-Based Complementary and Alternative Medicine, Vol. 2014. 
[9]. Choudhary, V., Choudhary, M., Pandey, S., Chauhan, V. D., & Hasnani, J. J. (2016). Maggot debridement therapy as primary tool 
to treat chronic wound of animals. Veterinary World, 9(4), 403–409. 
[10]. Davies, C. E., Woolfrey, G., Hogg, N., Dyer, J., Cooper, A., Waldron, J., … Poskitt, K. R. (2015). Maggots as a wound 
debridement agent for chronic venous leg ulcers under graduated compression bandages: A randomised controlled trial. Phlebology, 
30(10).  
[11]. Stadler, F., Shaban, R. Z., & Tatham, P. (2015). Maggot Debridement Therapy in Disaster Medicine. Prehospital and Disaster 
Medicine, 31(1).  
[12]. Rosen, S., Mirabzadeh, A., Ladani, M., Sharifi, S., Mashayekhi, M., Azema, M., Sherman, R. (2014). Maggot therapy is improving 
wound care in resource-limited populations. Journal of Investigative Medicine, 62(1), 274.  
[13]. Davydov, L. (2011). Maggot therapy in wound management in modern era and a review of published literature. Journal of 
Pharmacy Practice, Vol. 24 
[14]. Zarchi, Kian, & Jemec, G. B. (2012). The efficacy of maggot debridement therapy - a review of comparative clinical trials. 
International Wound Journal, 9(5), 469–477. 
[15]. Steenvoorde, Pascal, Jacobi, C. E., Van Doorn, L., & Oskam, J. (2007). Maggot debridement therapy of infected ulcers: Patient and 
wound factors influencing outcome - A study on 101 patients with 117 wounds. Annals of the Royal College of Surgeons of 
England, 89(6), 596–602 
[16]. Edwards, J., & Stapley, S. (2010). Debridement of diabetic foot ulcers. Cochrane Database of Systematic Reviews. 
[17]. Cazander, G., Gottrup, F., & Jukema, G. N. (2009). Maggot therapy for wound healing: clinical relevance, mechanisms of action 
and future prospects. Journal of Wound Technology, 5(July), 18–23. 
[18]. Gilead, L., Mumcuoglu, K. Y., & Ingber, A. (2012). The use of maggot debridement therapy in the treatment of chronic wounds in 
hospitalised and ambulatory patients. Journal of Wound Care, 21(2), 78, 80, 82–85.  
[19]. Gottrup, F., & Apelqvist, J. (2012). Present and new techniques and devices in the treatment of DFU: a critical review of evidence. 
Diabetes/Metabolism Research and Reviews, 28, 64–71. 
[20]. Gottrup, F., & Jørgensen, B. (2011). Maggot debridement: an alternative method for debridement. Eplasty, 11, e33. 
[21]. Bazaliński, D., Kózka, M., Karnas, M., & Więch, P. (2019). Effectiveness of Chronic Wound Debridement with the Use of Larvae 
of Lucilia Sericata. Journal of Clinical Medicine, 8(11), 1845.  
[22]. Nigam, Y., Bexfield, A., Thomas, S., & Ratcliffe, N. A. (2006). Maggot Therapy: The Science and Implication for CAM Part I-
History and Bacterial Resistance. Evidence-Based Complementary and Alternative Medicine : ECAM, 3(2), 223–227.  
[23]. Williams, K. A., Richards, C. S., & Villet, M. H. (2014). Predicting the geographic distribution of Lucilia sericata and Lucilia 
cuprina (Diptera: Calliphoridae) in South Africa. African Invertebrates, 55(1), 157–170.  
[24]. Tanyuksel, M, Araz, E., Koru, O., Yildiz, S., Ay, H., Yurttas, Y., Kilbas, Z. G. (2009). A remedy for chronic, non-healing wounds 
unresponsive to conventional therapy: Maggot debridement therapy. American Journal of Tropical Medicine and Hygiene, 81(5), 
15. 
[25]. Wilasrusmee, C., Marjareonrungrung, M., Eamkong, S., Attia, J., Poprom, N., Jirasisrithum, S., & Thakkinstian, A. (2014). Maggot 
therapy for chronic ulcer: A retrospective cohort and a meta-analysis. Asian Journal of Surgery, 37(3), 138–147. 
[26]. Paul, A. G., Ahmad, N. W., Lee, H., Ariff, A. M., Saranum, M., Naicker, A. S., & Osman, Z. (2009). Maggot debridement therapy 
with Lucilia cuprina: A comparison with conventional debridement in diabetic foot ulcers. International Wound Journal, 6(1), 39–
46.  
[27]. Tian, X., Liang, X. M., Song, G. M., Zhao, Y., & Yang, X. L. (2013). Maggot debridement therapy for the treatment of diabetic foot 
ulcers: a meta-analysis. Journal of Wound Care, 22(9), 462–469. 
[28]. Shi, E., & Shofler, D. (2014a). Maggot debridement therapy: a systematic review. British Journal of Community Nursing, Suppl 
Wound Care, S6-13 
[29]. Spilsbury, K., Cullum, N., Dumville, J., O’Meara, S., Petherick, E., & Thompson, C. (2008). Exploring patient perceptions of larval 
therapy as a potential treatment for venous leg ulceration. Health Expectations, 11(2), 148–159 
[30]. Yazdanpanah, L., Nasiri, M., & Adarvishi, S. (2015). Literature review on the management of diabetic foot ulcer. World Journal of 
Diabetes, 6(1), 37–53. 
[31]. Vilcinskas, A. (2011). From traditional maggot therapy to modern biosurgery. In Insect Biotechnology (Vol. 2, pp. 67–75). 
[32]. Gilead, L., Mumcuoglu, K. Y., & Ingber, A. (2012). The use of maggot debridement therapy in the treatment of chronic wounds in 
Effectiveness of Maggot Debridement Therapy (Luciliacuprina) In the Treatment of Diabetic Foot .. 
DOI: 10.9790/1959-0902025056                                 www.iosrjournals.org                                             56 | Page 
hospitalised and ambulatory patients. Journal of Wound Care, 21(2), 78, 80, 82–85. 
[33]. Hall, S. (2010). A review of maggot debridement therapy to treat chronic wounds. British Journal of Nursing, 19(15), S26–S31. 
 
 
Pirehma Marimuthu,etal. “Effectiveness of Maggot Debridement Therapy (Luciliacuprina) In the 
Treatment of Diabetic Foot Ulcer.” IOSR Journal of Nursing and Health Science (IOSR-JNHS), 
9(2), 2020, pp. 50-56. 
 
 
 
 
